At RARE-NL, we believe that collaboration is key to accelerating the development of therapies for rare diseases and the use of drug repurposing. In a field where complex challenges are central, innovative solutions are needed. Therefore, we are committed to public-private partnerships (PPPs) that have the potential to pave the way for new treatments, including the repurposing of existing drugs (drug repurposing). By uniting academic institutions, patient organisations and large and small pharmaceutical and biotech companies, we create a valuable chain that covers the entire process: from basic research to final drug approval.

Support services by RARE-NL

Sharing knowledge
RARE-NL facilitates knowledge sharing through various channels such as educational platforms, our website, events and presentations, the FAST Forum. That questions can be sent via team members or via the contact form.

Advice on cases
Where necessary, we offer one-off, no-obligation advice around a case, possibly involving external expertise.

Sustainable partnerships
We support the establishment of strategic and sustainable collaborations, aiming to realise innovative solutions and products. RARE-NL provides guidance on applying for support from bodies such as the EMA (European Medicines Agency) and the CBG (Medicines Evaluation Board).

Increasing availability
By formalising collaborations through agreements, we strengthen joint strength and commitment. Think of initiatives towards a product-BV, whether or not financially supported by RARE-NL.

Together, we are building a future where rare diseases no longer go untreated. Join RARE-NL and discover the added value of this collaboration.